(Q37905667)

25 August 2017

1 reference

title

Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies (English)

1 reference

25 August 2017

1

Pier Luigi Zinzani

1 reference

25 August 2017

Pier Paolo Piccaluga

2

1 reference

25 August 2017

language of work or name

1 reference

1 October 2011

1 reference

25 August 2017

published in

Current Oncology Reports

1 reference

25 August 2017

volume

13

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

407-415

1 reference

Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Mediastinal (thymic) large B-cell lymphoma: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Assignment of the T-cell differentiation gene MAL to human chromosome 2, region cen----q13

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Lipid rafts mediate biosynthetic transport to the T lymphocyte uropod subdomain and are necessary for uropod integrity and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

The human thymus contains a novel population of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

AID expression identifies interfollicular large B cells as putative precursors of mature B-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Primary mediastinal large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Mediastinal B-cell lymphoma: A study of its histomorphologic spectrum based on 109 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0189-5

Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP)

21 January 2018

1 reference

12 December 2020

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

12 December 2020

Primary mediastinal clear cell lymphoma of B-cell type

1 reference

12 December 2020

Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas.

1 reference

12 December 2020

Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases

1 reference

12 December 2020

Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens

1 reference

12 December 2020

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging

1 reference

12 December 2020

Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients

1 reference

12 December 2020

Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience

1 reference

12 December 2020

The role of lipid rafts in signalling and membrane trafficking in T lymphocytes

1 reference

12 December 2020

Expression of bcl-6 and CD10 in Primary Mediastinal Large B-Cell Lymphoma

1 reference

12 December 2020

Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features

1 reference

12 December 2020

Molecular characterization of primary mediastinal B cell lymphoma

1 reference

12 December 2020

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

1 reference

12 December 2020

Thymic medullary cells expressing B lymphocyte antigens

1 reference

12 December 2020

Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis

1 reference

12 December 2020

Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients

1 reference

12 December 2020

Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation

1 reference

12 December 2020

CNS involvement in primary mediastinal large B-cell lymphoma

1 reference

12 December 2020

MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis

1 reference

12 December 2020

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients

1 reference

12 December 2020

Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma

1 reference

12 December 2020

Stage II large B-cell lymphoma with sclerosis treated with MACOP-B

1 reference

12 December 2020

Primary non-Hodgkin's lymphoma of the mediastinum

1 reference

12 December 2020

Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.

1 reference

12 December 2020

Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia

1 reference

12 December 2020

MAL, a novel integral membrane protein of human T lymphocytes, associates with glycosylphosphatidylinositol-anchored proteins and Src-like tyrosine kinases

1 reference

12 December 2020

Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients

1 reference

12 December 2020

Primary large-cell lymphoma of the mediastinum

1 reference

12 December 2020

The MAL gene is expressed in primary mediastinal large B-cell lymphoma

1 reference

12 December 2020

Gains ofREL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein

1 reference

12 December 2020

Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy

1 reference

12 December 2020

Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma

1 reference

12 December 2020

Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients

1 reference

12 December 2020

Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene

1 reference

12 December 2020

Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients

1 reference

12 December 2020

Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study

1 reference

12 December 2020

Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients

1 reference

12 December 2020

Primary mediastinal large cell lymphoma (PMBL): frontline treatment with autologous stem cell transplantation (ASCT). The GEL-TAMO experience

1 reference

12 December 2020

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

1 reference

12 December 2020

CD23 expression in mediastinal large B-cell lymphomas

1 reference

12 December 2020

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

1 reference

12 December 2020

Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study.

1 reference

12 December 2020

Report of the Committee on Hodgkin's Disease Staging Classification

1 reference

12 December 2020

Primary mediastinal lymphoma in adults

1 reference

12 December 2020

Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy

1 reference

12 December 2020

Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy

1 reference

12 December 2020

CD30 expression is common in mediastinal large B-cell lymphoma

1 reference

12 December 2020

10.1007/S11912-011-0189-5

Identifiers

DOI

1 reference

25 August 2017

1 reference